Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Summary

Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays.

However, the pharmacological treatment of diabesity has made significant progress in recent years.

The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:

1. to determine the prevalence of causes and duration of hospitalization
2. to investigate the treatments used
3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.

Conditions

• Diabetes Mellitus
• Obesity

Interventions

OTHER

Routine care for people with diabetes, with or without obesity, in the hospital setting

Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.

Sponsors & Collaborators

• Hospital de Cascais Dr. José de Almeida (Portugal)

  collaborator UNKNOWN

• Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria)

  collaborator UNKNOWN

• Rabin Medical Center

  collaborator OTHER

• Hospital Regional de Malaga

  collaborator OTHER

• Charles University, Czech Republic

  collaborator OTHER

• University Hospital Bratislava

  collaborator OTHER

• Complejo Hospitalario de Especialidades Juan Ramón Jimenez

  collaborator UNKNOWN

• Medical University Innsbruck

  collaborator OTHER

• Aristotle University Of Thessaloniki

  collaborator OTHER

• Rostov State Medical University

  collaborator UNKNOWN

• Hospital Marina Baixa

  collaborator UNKNOWN

• Riga East Clinical University Hospital

  collaborator OTHER_GOV

• University Hospital, Aachen

  collaborator OTHER

• San Raffaele University Hospital, Italy

  collaborator OTHER

• Kanuni Sultan Suleyman Training and Research Hospital

  collaborator OTHER

• Medical University of Vienna

  lead OTHER

Principal Investigators

• Alexandra Kautzky-Willer, Prof · Medical University of Vienna

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-11-13

Primary Completion

2025-03-18

Completion

2025-05-31

Countries

• Austria
• Czechia
• Germany
• Greece
• Israel
• Latvia
• Russia
• Turkey (Türkiye)

Study Locations